Physician profile
Haley Ellis
NPI 1306485172
$4,948.29
in general payments reported to CMS, 2019-2025
23 companies · $739 in 2025
The $739 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $452 · 2022: $757 · 2023: $854 · 2024: $2,146 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,317 · Travel and Lodging: $1,236 · Education: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,317.40 |
| Travel and Lodging | $1,236.15 |
| Education | $185.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,236.15 | 2024 | |
| Mylan Specialty L.P. | $881.51 | 2022-2024 | Yupelri |
| Astrazeneca Pharmaceuticals LP | $872.72 | 2021-2025 | Tezspire, Breztri, Airsupra |
| Janssen Pharmaceuticals, INC | $218.05 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $191.87 | 2024-2025 | Uptravi, Opsumit |
| Verona Pharma, INC. | $173.32 | 2025 | Ohtuvayre |
| E.R. Squibb & Sons, L.L.C. | $164.65 | 2021-2025 | Camzyos |
| Grifols USA, LLC | $163.52 | 2022-2025 | Prolastin-C Liquid |
| Baxter Healthcare | $162.05 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Glaxosmithkline, LLC. | $160.44 | 2022-2025 | Nucala, Trelegy Ellipta |
| Insmed, INC. | $134.12 | 2024-2025 | Arikayce, Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.57 | 2021-2023 | Stiolto Respimat |
| Genzyme Corporation | $126.37 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.48 | 2021-2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $61.06 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $54.00 | 2024-2025 | Dupixent |
| Bayer Healthcare Pharmaceuticals INC. | $41.68 | 2022-2024 | |
| Sanofi US Services INC. | $22.24 | 2024 | |
| Amgen INC. | $18.83 | 2025 | Tezspire |
| Itamar Medical INC | $17.64 | 2023 | Watchpatone |
| Teva Pharmaceuticals USA, INC. | $16.41 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.41 | 2022 | |
| Amarin Pharma, INC. | $11.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.